Indeed, previous studies have shown that KRAS mutant cancers are more sensitive to oxidative stress (131, 132); moreover, a recent study has exhibited that in NSCLC with KRAS mutations there is an altered expression of genes involved in metabolism upon glutamine deprivation, confirming the relationship between KRAS mutations and oxidative stress susceptibility (133). This evidence concerns the gene KRAS and cancer.